Shalby informs about appointment of additional director

19 Oct 2022 Evaluate

Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shalby has informed that the Board of Directors of the Company at the meeting held on October 18, 2022, which commenced at 4:00 pm and concluded at 5:35 pm, have considered and approved the following: Appointment of Vijay Kedia (DIN: 00230480) as an Additional Director (Non?Executive Non? Independent) with effect from October 18, 2022, subject to approval of members of the Company. The details for appointment of above directors, as required under Regulation 30(6) read with Schedule III Part A para-A (7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015 have been provided in Annexure – A.  

The above information is a part of company’s filings submitted to BSE.

Shalby Share Price

204.40 7.00 (3.55%)
31-Dec-2025 15:28 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7040.00
Max Healthcare Inst 1043.65
Narayana Hrudayalay 1890.00
Aster DM Healthcare 617.95
Global Health 1185.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×